Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Heterozygous loss of Srp72 in mice is not associated with major hematological phenotypes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Addressing the room for improvement in management of acute promyelocytic leukemia

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Risk factors for infections in newly diagnosed Multiple Myeloma patients: A Danish retrospective nationwide cohort study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Statin treatment, oxidative stress and inflammation in a Danish population

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. High frequencies of circulating memory T cells specific for calreticulin exon 9 mutations in healthy individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. The effectiveness of exercise-based rehabilitation to patients with myeloproliferative neoplasms-An explorative study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Myeloproliferative Neoplasms in Danish Twins

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Chronic myeloproliferative neoplasms (MPN), encompassing essential thrombocythaemia (ET), polycythaemia vera (PV) and myelofibrosis (PMF), are featured by a chronic inflammatory state which is pronounced in myelofibrosis The value of YKL-40 as a biomarker of disease burden has been demonstrated in several different diseases, including cancer, diabetes mellitus and cardiovascular diseases. A state of chronic inflammation is shared by them all, YKL-40 also being involved in the severity of chronic endothelial inflammation, which today is considered of crucial importance for the development of atherosclerosis. The MPNs being cancers with a heavy burden of cardiovascular diseases we hypothesised that circulating YKL-40 might reflect the inflammatory process and potentially serve as a novel disease marker. Using ELISA, we measured YKL-40 in 15 patients with ET, 16 patients with PV, 17 patients with PMF and 30 healthy controls. YKL-40 was significantly elevated in PMF vs. control subjects, PMF levels median 43 ng/mL vs. controls median 28 ng/mL, P = 0.033. An increase from ET over PV may reflect the integrated impact of disease processes in MPNs.

OriginalsprogEngelsk
TidsskriftEuropean Journal of Haematology
Vol/bind93
Udgave nummer3
Sider (fra-til)224-8
Antal sider5
ISSN0902-4441
DOI
StatusUdgivet - sep. 2014

ID: 45944340